From CNBC:

A major ETF provider is launching funds focusing on tech giants and weight loss drugs. Roundhill Investments prepares to release a fund centered on GLP-1 drug companies. Leveraged and inverse ETFs tracking top tech stocks were recently launched. MAGX profits from gains of tech giants, while MAGQ allows negative bets on the group. Both funds reset daily and are considered risky options for investors. VettaFi cautions on the volatility of leveraged and inverse ETFs, comparing them to playing baseball and taking risky swings. Since their debut, MAGX is up almost 7%, while MAGQ is down nearly 4%.



Read more: New funds target weight loss, Big Tech hype: Roundhill Investments